BioSpace News Archive

DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) (“DelMar” or the “Company”), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, announced today the acceptance of an invitation from the Global Coalition for Adaptive Research (GCAR) to include VAL-083 in GCAR’s Glioblastoma Adaptive Global Innovative Learning Environment (GBM AGILE) Study,

Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (Qualigen or the Company) announced today that the United States Patent and Trademark Office has issued a Notice of Allowance for a U.S. patent, which will be issued to the Company, titled “Devices and Methods for On-Line Whole Blood Treatment” regarding the Company’s Selective Target Anti

Pendulum Therapeutics , a cutting-edge microbiome company dedicated to making people healthier through microbiome-targeted solutions, announced today the launch of Pendulum Glucose Control, the first and only medical probioti

MedHub Ltd., a medical technology company focused on developing and commercializing AI powered medical solutions that aid in the diagnosis of cardiac disease, announced that is has gained AMAR approval for its AutocathFFR system.

Intravacc, one of the world’s leading translational research and development vaccine institutes, with an extensive track record in developing viral and bacterial vaccines, has announced more details on its development of an intranasal vaccine against COVID-19.

Seven Bridges, the industry-leading bioinformatics ecosystem provider, today announced the successful completion of independent examinations for SOC 2 Type 2, SOC 3 and HIPAA. The examinations were conducted by independent service auditor Schellman and Company, LLC. These additions to the Seven Bridges compliance portfolio complement the compa

Mylan N.V. (NASDAQ: MYL) and Lupin Limited (Lupin) today announced that the European Commission (EC) has granted marketing authorization for Nepexto ® , a biosimilar to Enbrel ® (etanercept), for all indications of the reference product including rheumatoid arthritis, juvenile idiopathic art

Taiho Oncology, Inc. today announced that preclinical data for futibatinib (TAS-120) will be presented online during the American Association for Cancer Research (AACR) Virtual Annual Meeting II 2020 from June 22-24 . Key presentations include:

MYOS RENS Technology Inc. (“MYOS”) (NASDAQ: MYOS), a bionutrition company and the owner of Fortetropin ® , a proprietary bioactive composition that helps build lean muscle, announced today that it wi

As states across the nation start phased re-openings, companies are determining how to return their employees, clients and vistors to the office safely.